Global Information
회사소개 | 문의 | 비교리스트

유럽의 수술 로봇 시스템 시장 분석(2017년)

Europe Market Report for Surgical Robotics Systems 2017 - MedCore

리서치사 iData Research Inc.
발행일 2016년 12월 상품 코드 409634
페이지 정보 영문 179 Pages
가격
US $ 6,495 ₩ 7,819,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄는 불가능합니다.
US $ 7,794 ₩ 9,383,000 PDF by E-mail (Site License) help
동일 사업장 내에서 공유하여 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,743 ₩ 11,730,000 PDF by E-mail (Corporate License) help
동일 기업의 모든 분이 이용할 수 있는 글로벌 라이선스입니다. 이용 인원수에 제한은 없습니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



유럽의 수술 로봇 시스템 시장 분석(2017년) Europe Market Report for Surgical Robotics Systems 2017 - MedCore
발행일 : 2016년 12월 페이지 정보 : 영문 179 Pages

유럽 국가에서는 최근 척추 수술을 중심으로 저침습적 수술(MIS)이 보급됨에 따라 로봇 지원형 수술 플랫폼도 폭넓게 이용되고 있습니다. 수술 로봇을 사용한 척추 수술의 역사는 아직 짧으나, 입원·회복기간의 단축에 의해 향후 시장 확대 경향이 계속될 전망입니다.

유럽 국가의 수술 로봇 시스템 시장을 분석했으며, 전체적인 시장 규모 동향 전망(판매량·매출액·평균 가격, 시장 성장률 등), 제품 카테고리별 상세 동향, 주요 시장 촉진·억제요인, 최근 자본거래 동향·시장 구도, 기업별 시장 점유율 등의 조사·추산, 시장의 전체적 경향(질환·제품 개요, 시술 건수, 임상시험 동향 등)에 관한 정보를 정리하여 전해드립니다.

1. 개요

2. 유럽의 수술 로봇·수술 내비게이션 시장 : 개요

3. 경쟁 분석

4. 시장 경향

5. 시장의 발전

6. 분석 대상 시술

7. 분석 대상 시장

8. 주요 분석 업데이트 상황

9. 과거 버전

10. 분석 방법

  • 분석 범위
  • IDATA의 9단계 분석 방법

11. 질환 개요

  • 의학적 증상
    • 뇌신경외과계 질환
      • 수두증
      • 교통성 수두증
      • 정상압수두증
      • 비교통성 수두증
      • 뇌종양
      • 두개내압
      • 두개내 동맥류
      • 두개내 아테롬성 동맥경화증
    • 척추계 질환
      • 추간판 헤르니아
      • 척주관 협착증
      • 척추증
      • 척추측만증
      • 척추전만증
      • 척추후만증
    • 이비인후과(ENT)계 질환
      • 중이염
      • 진주종
      • 이경화증
      • 만성 부비동염
      • 편도선
    • 정형외과계 질환
      • 골절
      • 골다공증
      • 관절염
    • 부인과계 질환
      • 부인과계 암
      • 자궁근종
      • 자궁내막증
      • 월경 과다
      • 골반 탈출증
    • 비뇨기계 질환
      • 전립선암
      • 방광암
      • 신장암
      • 전립선 비대증(BPH)
    • 소화관계 질환
      • 분문 경련증
      • 위암
      • 헤르니아
      • 담낭 발작
      • 위식도 역류증
    • 대장(결장직장) 질환
      • 대장암
      • 염증성 대장 질환
      • 게실염
    • 심장 질환
      • 승모판 일탈증
      • 관상동맥 질환

12. 제품 평가

  • 로봇 지원 수술(RAS) 제품 포트폴리오
    • 로봇 지원 수술 개요
    • 신경외과 수술
    • 척추 수술
    • 정형외과 수술
    • 저침습적 수술
    • 방사선 수술
    • 카테터 설치
  • 수술 로봇 : 규제상 문제와 리콜
    • Accuray Inc.
    • Blue Belt Technologies
    • Hansen Medical Inc.
    • Intuitive Surgical
    • MAKO Surgical/Stryker
    • OMNIlife Science
  • 임상시험 상황
  • 수술 로봇의 임상시험 동향
    • Accuray Inc.
    • Catheter Precision
    • Corindus Inc
    • Hansen Medical
    • Intuitive Surgical
    • MAKO Surgical/Stryker
    • Mazor
    • Medrobotics
    • Medtech

13. 수술 로봇 시장

  • 서론
  • 척추 수술용 로봇 지원 시스템 시장
    • 서론
    • 시장 분석과 예측
    • 시장 촉진·억제요인
      • 시장 성장 촉진요인
      • 시장 성장 억제요인
    • 주요 기업
    • 신규 기업
  • 신경외과 수술용 로봇 지원 시스템 시장
  • 저침습적 수술용 로봇 지원 시스템 시장
  • 방사선 수술용 로봇 지원 시스템 시장
  • 카테터 설치용 로봇 시스템 시장
  • 정형외과 수술용 로봇 지원 시스템 시장

14. 약어 리스트

15. 부록 : 각 기업의 프레스 릴리스

16. 도표

KSA 17.01.10

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Minimally invasive surgery (MIS) has become a priority in most surgical disciplines including spinal surgery. The natural evolution of equipment has yielded robotic assisted surgery platforms which provide MIS. However, robotic spine surgery is still very new; it is less than ten years old. In the European market, there are currently only two systems that have been approved. The technology benefits the surgeon by allowing for smaller incisions, MIS, and the technology which guides the surgeon. The main goal is to decrease hospital stay, decrease healing time and improve the surgery experience. Due to the infancy of the market, the future is unknown; however, short term studies have demonstrated clear benefits of using robotic systems for spine surgery.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN ROBOTICS AND SURGICAL NAVIGATION MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURES COVERED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. MEDICAL CONDITIONS
    • 2.1.1. Neurosurgery Conditions
      • 2.1.1.1. Hydrocephalus
      • 2.1.1.2. Communicating Hydrocephalus
      • 2.1.1.3. Normal Pressure Hydrocephalus
      • 2.1.1.4. Non-Communicating Hydrocephalus
      • 2.1.1.5. Brain Tumor
      • 2.1.1.6. Intracranial Pressure
      • 2.1.1.7. Intracranial Aneurysm
      • 2.1.1.8. Intracranial Atherosclerosis Disease
    • 2.1.2. Spinal Conditions
      • 2.1.2.1. Herniated Disc
      • 2.1.2.2. Spinal Stenosis
      • 2.1.2.3. Spondylosis
      • 2.1.2.4. Scoliosis
      • 2.1.2.5. Lordosis
      • 2.1.2.6. Kyphosis
    • 2.1.3. ENT Conditions
      • 2.1.3.1. Otitis Media
      • 2.1.3.2. Cholesteatomas
      • 2.1.3.3. Otosclerosis
      • 2.1.3.4. Chronic Sinusitis
      • 2.1.3.5. Tonsillitis
    • 2.1.4. Orthopedic Conditions
      • 2.1.4.1. Fractures
      • 2.1.4.2. Osteoporosis
      • 2.1.4.3. Arthritis
    • 2.1.5. Gynecological Conditions
      • 2.1.5.1. Gynecological Cancers
      • 2.1.5.2. Uterine Fibroids
      • 2.1.5.3. Endometriosis
      • 2.1.5.4. Menorrhagia
      • 2.1.5.5. Pelvic Prolapse
    • 2.1.6. Urological Conditions
      • 2.1.6.1. Prostate Cancer
      • 2.1.6.2. Bladder Cancer
      • 2.1.6.3. Kidney Cancer
      • 2.1.6.4. Benign Prostate Hyperplasia (BPH)
    • 2.1.7. Digestive Tract Conditions
      • 2.1.7.1. Achalasia
      • 2.1.7.2. Stomach Cancer
      • 2.1.7.3. Hernia
      • 2.1.7.4. Gallbladder Attack
      • 2.1.7.5. Gastroesophageal Reflex Disease
    • 2.1.8. Colorectal Conditions
      • 2.1.8.1. Colorectal Cancer
      • 2.1.8.2. Inflammatory Bowel Disease
      • 2.1.8.3. Diverticulitis
    • 2.1.9. Cardiac Conditions
      • 2.1.9.1. Mitral Valve Prolapse
      • 2.1.9.2. Coronary Artery Disease

PRODUCT ASSESSMENT

  • 3.1. ROBOTIC ASSISTED SURGERY PRODUCT PORTFOLIOS
    • 3.1.1. Robotic-Assisted Surgery Overview
    • 3.1.2. Neurosurgery
    • 3.1.3. Spine Surgery
    • 3.1.4. Orthopedic Surgery
    • 3.1.5. Minimally Invasive Surgery
    • 3.1.6. Radiosurgery
    • 3.1.7. Catheter Placement
  • 3.2. RAS REGULATORY ISSUES AND RECALLS
    • 3.2.1. Accuray Inc.
    • 3.2.2. Blue Belt Technologies
    • 3.2.3. Hansen Medical Inc.
    • 3.2.4. Intuitive Surgical
    • 3.2.5. MAKO Surgical/Stryker
    • 3.2.6. OMNIlife Science
  • 3.3. CLINICAL TRIALS
  • 3.4. RAS CLINICAL TRIALS
    • 3.4.1. Accuray Inc.
    • 3.4.2. Catheter Precision
    • 3.4.3. Corindus Inc
    • 3.4.4. Hansen Medical
    • 3.4.5. Intuitive Surgical
    • 3.4.6. MAKO Surgical/Stryker
    • 3.4.7. Mazor
    • 3.4.8. Medrobotics
    • 3.4.9. Medtech

SURGICAL ROBOTICS MARKET

  • 4.1. INTRODUCTION
  • 4.2. SPINE ROBOTIC ASSISTED SURGERY SYSTEM MARKET
    • 4.2.1. Introduction
    • 4.2.2. Market Analysis and Forecast
    • 4.2.3. Drivers and Limiters
      • 4.2.3.1. Market Drivers
      • 4.2.3.2. Market Limiters
    • 4.2.4. Leading Competitors
    • 4.2.5. Emerging Competitors
  • 4.3. NEUROSURGERY ROBOTIC ASSISTED SURGERY SYSTEM MARKET
    • 4.3.1. Introduction
    • 4.3.2. Market Analysis and Forecast
    • 4.3.3. Drivers and Limiters
      • 4.3.3.1. Market Drivers
      • 4.3.3.2. Market Limiters
    • 4.3.4. Leading Competitors
    • 4.3.5. Emerging Competitors
  • 4.4. MINIMALLY INVASIVE SURGERY ROBOTIC DEVICE MARKET
    • 4.4.1. Introduction
    • 4.4.2. Market Analysis and Forecast
    • 4.4.3. Drivers and Limiters
      • 4.4.3.1. Market Drivers
      • 4.4.3.2. Market Limiters
    • 4.4.4. Leading Competitors
    • 4.4.5. Emerging Competitors
  • 4.5. ROBOTIC RADIOSURGERY DEVICE MARKET
    • 4.5.1. Introduction
    • 4.5.2. Market Analysis and Forecast
    • 4.5.3. Drivers and Limiters
      • 4.5.3.1. Market Drivers
      • 4.5.3.2. Market Limiters
    • 4.5.4. Leading Competitors
  • 4.6. ROBOTIC CATHETER SYSTEM MARKET
    • 4.6.1. Introduction
    • 4.6.2. Market Analysis and Forecast
    • 4.6.3. Drivers and Limiters
      • 4.6.3.1. Market Drivers
      • 4.6.3.2. Market Limiters
    • 4.6.4. Leading Competitors
  • 4.7. ROBOTIC ASSISTED ORTHOPEDIC SURGERY MARKET
    • 4.7.1. Introduction
    • 4.7.2. Market Analysis and Forecast
    • 4.7.3. Drivers and Limiters
      • 4.7.3.1. Market Drivers
      • 4.7.3.2. Market Limiters
    • 4.7.4. Leading Competitors

ABBREVIATIONS

APPENDIX: COMPETITOR PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Surgical Navigation System Market by Segment, Europe, 2013 - 2023
  • Chart 1-2: Robotic Assisted Surgery Market by Segment, Europe, 2013 - 2023
  • Chart 1-3: Robotics and Surgical Navigation Market Overview, Europe, 2016 & 2023
  • Chart 4-1: Spine Robotic Assisted Surgery System Market, Europe, 2013 - 2023
  • Chart 4-2: Leading Competitors, Spine Robotic Assisted Surgery System Market, Europe, 2016
  • Chart 4-3: Neurosurgery Robotic Assisted Surgery System Market, Europe, 2013 - 2023
  • Chart 4-4: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
  • Chart 4-5 Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023
  • Chart 4-6: Leading Competitors, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
  • Chart 4-7 Robotic Radiosurgery Device Market, Europe, 2013 - 2023
  • Chart 4-8: Robotic Catheter System Market, Europe, 2013 - 2023
  • Chart 4-9: Leading Competitors by Country, Robotic Catheter System Market, Europe, 2016
  • Chart 4-10: Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023
  • Chart 4-11: Leading Competitors by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2016

LIST OF FIGURES

  • Figure 1-1: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
  • Figure 1-2: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
  • Figure 1-3: Companies Researched in this Report, Europe, 2016
  • Figure 1-4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, Europe
  • Figure 1-5: Recent Events in the Robotics and Surgical Navigation Market, Europe, 2012 - 2016
  • Figure 1-6: Robotics and Surgical Navigation Procedures Covered, Europe, 2016
  • Figure 1-7: Robotics and Surgical Navigation Markets Covered, Europe, 2016 (1 of 2)
  • Figure 1-8: Robotics and Surgical Navigation Markets Covered, Europe, 2016 (2 of 2)
  • Figure 1-9: Key Report Updates
  • Figure 1-10: Version History
  • Figure 3-1: Robot-Assisted Neurosurgery Products by Company
  • Figure 3-2: Robot-Assisted Spine Surgery Products by Company
  • Figure 3-3: Robot-Assisted Orthopedic Surgery Products by Company
  • Figure 3-4: Robot-Assisted Radiosurgery Products by Company
  • Figure 3-5: Robot-Assisted Catheter Placement Products by Company
  • Figure 3-6: Class 2 Device Recall Accuray Inc
  • Figure 3-7: Class 2 Device Recall Accuray Inc
  • Figure 3-8: Class 2 Device Recall Accuray Inc
  • Figure 3-9: Class 2 Device Recall Accuray Inc
  • Figure 3-10: Class 2 Device Recall Accuray Inc
  • Figure 3-11: Class 2 Device Recall Accuray Inc
  • Figure 3-12: Class 2 Device Recall Blue Belt Technologies
  • Figure 3-13: Class 2 Device Recall Blue Belt Technologies
  • Figure 3-14: Class 2 Device Recall Blue Belt Technologies
  • Figure 3-15: Class 2 Device Recall Hansen Medical
  • Figure 3-16: Class 2 Device Recall Hansen Medical
  • Figure 3-17: Class 2 Device Recall Hansen Medical
  • Figure 3-18: Class 2 Device Recall Intuitive Surgical
  • Figure 3-19: Class 2 Device Recall Intuitive Surgical
  • Figure 3-20: Class 2 Device Recall Intuitive Surgical
  • Figure 3-21: Class 2 Device Recall Intuitive Surgical
  • Figure 3-22: Class 2 Device Recall Intuitive Surgical
  • Figure 3-23: Class 2 Device Recall Intuitive Surgical
  • Figure 3-24: Class 2 Device Recall Intuitive Surgical
  • Figure 3-25: Class 2 Device Recall Intuitive Surgical
  • Figure 3-26: Class 2 Device Recall Intuitive Surgical
  • Figure 3-27: Class 2 Device Recall Intuitive Surgical
  • Figure 3-28: Class 2 Device Recall Intuitive Surgical
  • Figure 3-29: Class 2 Device Recall Intuitive Surgical
  • Figure 3-30: Class 2 Device Recall Intuitive Surgical
  • Figure 3-31: Class 2 Device Recall Intuitive Surgical
  • Figure 3-32: Class 2 Device Recall Intuitive Surgical
  • Figure 3-33: Class 2 Device Recall Intuitive Surgical
  • Figure 3-34: Class 2 Device Recall Intuitive Surgical
  • Figure 3-35: Class 2 Device Recall Intuitive Surgical
  • Figure 3-36: Class 2 Device Recall Intuitive Surgical
  • Figure 3-37: Class 2 Device Recall Intuitive Surgical
  • Figure 3-38: Class 2 Device Recall Intuitive Surgical
  • Figure 3-39: Class 2 Device Recall Intuitive Surgical
  • Figure 3-40: Class 2 Device Recall Intuitive Surgical
  • Figure 3-41: Class 2 Device Recall Intuitive Surgical
  • Figure 3-42: Class 2 Device Recall Intuitive Surgical
  • Figure 3-43: Class 2 Device Recall Intuitive Surgical
  • Figure 3-44: Class 2 Device Recall Intuitive Surgical
  • Figure 3-45: Class 2 Device Recall Intuitive Surgical
  • Figure 3-46: Class 2 Device Recall Intuitive Surgical
  • Figure 3-47: Class 2 Device Recall Intuitive Surgical
  • Figure 3-48: Class 2 Device Recall Intuitive Surgical
  • Figure 3-49: Class 2 Device Recall Intuitive Surgical
  • Figure 3-50: Class 2 Device Recall Intuitive Surgical
  • Figure 3-51: Class 2 Device Recall Intuitive Surgical
  • Figure 3-52: Class 2 Device Recall Intuitive Surgical
  • Figure 3-53: Class 2 Device Recall Intuitive Surgical
  • Figure 3-54: Class 2 Device Recall Intuitive Surgical
  • Figure 3-55: Class 2 Device Recall Intuitive Surgical
  • Figure 3-56: Class 2 Device Recall Intuitive Surgical
  • Figure 3-57: Class 2 Device Recall Intuitive Surgical
  • Figure 3-58: Class 2 Device Recall Intuitive Surgical
  • Figure 3-59: Class 2 Device Recall Intuitive Surgical
  • Figure 3-60: Class 2 Device Recall Intuitive Surgical
  • Figure 3-61: Class 2 Device Recall Intuitive Surgical
  • Figure 3-62: Class 2 Device Recall Intuitive Surgical
  • Figure 3-63: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-64: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-65: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-66: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-67: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-68: Class 2 Device Recall MAKO Surgical/Stryker
  • Figure 3-69: Class 2 Device Recall OMNIlife Science, Inc
  • Figure 3-70: Class 2 Device Recall OMNIlife Science, Inc
  • Figure 3-71: Class 2 Device Recall OMNIlife Science, Inc
  • Figure 3-72: Class 2 Device Recall OMNIlife Science, Inc
  • Figure 3-73: Class 2 Device Recall OMNIlife Science, Inc
  • Figure 3-74: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer
  • Figure 3-75: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer
  • Figure 3-76: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors
  • Figure 3-77: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients
  • Figure 3-78: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors
  • Figure 3-79: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer
  • Figure 3-80: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
  • Figure 3-81: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI)
  • Figure 3-82: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy
  • Figure 3-83: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
  • Figure 3-84: Stereotactic Radiosurgery for Soft Tissue Sarcoma
  • Figure 3-85: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
  • Figure 3-86: Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System
  • Figure 3-87: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus
  • Figure 3-88: Manual vs Amigo SmartTouch Atrial Fibrillation Study (MAST-AF)
  • Figure 3-89: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)
  • Figure 3-90: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)
  • Figure 3-91: Post-Market CorPath Registry on the CorPath 200 System
  • Figure 3-92: Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System
  • Figure 3-93: Registry of the Magellan Robotic System (ROVER)
  • Figure 3-94: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
  • Figure 3-95: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System
  • Figure 3-96: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci
  • Figure 3-97: Robotic-assisted Versus Laparoscopic Sigmoid Resection
  • Figure 3-98: Prospective Investigation of Robotic Single-port System
  • Figure 3-99: Clinical Outcomes of Knee Replacement
  • Figure 3-100: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot
  • Figure 3-101: Robotic Arm Assisted Total Knee Arthroplasty
  • Figure 3-102: Outcomes of Robotic Total Hip Arthroplasty
  • Figure 3-103: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement
  • Figure 3-104: Prospective, Observational Registry of Renaissance-guided Spine Surgeries
  • Figure 3-105: Clinical Trial of Minimally Invasive Robotic Spine Surgery
  • Figure 3-106: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI)
  • Figure 3-107: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
  • Figure 3-108: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries
  • Figure 3-109: A Post-Market Clinical Trial for Access and Visualization
  • Figure 3-110: Robotic-assisted Pedicule Screw Placement (ARASS)
  • Figure 4-1: Spine Robotic Assisted Surgery System Market, Europe, 2013 - 2023 (€)
  • Figure 4-2: Units Sold by Country, Spine Robotic Assisted Surgery System, Europe, 2013 - 2023
  • Figure 4-3: ASP by Country, Spine Robotic Assisted Surgery System, Europe, 2013 - 2023 (€)
  • Figure 4-4: ASP by Country, Spine Robotic Assisted Surgery System, Europe, 2013 - 2023 (US$)
  • Figure 4-5: Market Value by Country, Spine Robotic Assisted Surgery System, Europe, 2013 - 2023 (€M)
  • Figure 4-6: Market Value by Country, Spine Robotic Assisted Surgery System, Europe, 2013 - 2023 (US$M)
  • Figure 4-7: Drivers and Limiters, Spine Robotic Assisted Surgery System Market, Europe, 2016
  • Figure 4-8: Leading Competitors, Spine Robotic Assisted Surgery System Market, Europe, 2016
  • Figure 4-9: Neurosurgery Robotic Assisted Surgery System Market, Europe, 2013 - 2023 (€)
  • Figure 4-10: Units Sold by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 - 2023
  • Figure 4-11: ASP by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 - 2023 (€)
  • Figure 4-12: ASP by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 - 2023 (US$)
  • Figure 4-13: Market Value by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 - 2023 (€M)
  • Figure 4-14: Market Value by Country, Neurosurgery Robotic Assisted Surgery System, Europe, 2013 - 2023 (US$M)
  • Figure 4-15: Drivers and Limiters, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
  • Figure 4-16: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, Europe, 2016
  • Figure 4-17: Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023 (€)
  • Figure 4-18: Units Sold by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023
  • Figure 4-19: ASP by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023 (€)
  • Figure 4-20: ASP by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023 (US$)
  • Figure 4-21: Market Value by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023 (€M)
  • Figure 4-22: Market Value by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2013 - 2023 (US$M)
  • Figure 4-23: Drivers and Limiters, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
  • Figure 4-24: Leading Competitors by Country, Minimally Invasive Surgery Robotic Device Market, Europe, 2016
  • Figure 4-25: Robotic Radiosurgery Device Market, Europe, 2013 - 2023
  • Figure 4-26: Units Sold by Country, Robotic Radiosurgery Device Market, Europe, 2013 - 2023
  • Figure 4-27: ASP by Country, Robotic Radiosurgery Device Market, Europe, 2013 - 2023 (€)
  • Figure 4-28: ASP by Country, Robotic Radiosurgery Device Market, Europe, 2013 - 2023 (US$)
  • Figure 4-29: Market Value by Country, Robotic Radiosurgery Device Market, Europe, 2013 - 2023 (€M)
  • Figure 4-30: Market Value by Country, Robotic Radiosurgery Device Market, Europe, 2013 - 2023 (US$M)
  • Figure 4-31: Drivers and Limiters, Robotic Radiosurgery Device Market, Europe, 2016
  • Figure 4-32: Leading Competitors, Robotic Radiosurgery Device Market, Europe, 2016
  • Figure 4-33: Robotic Catheter System Market, Europe, 2013 - 2023
  • Figure 4-34: Units Sold by Country, Robotic Catheter System Market, Europe, 2013 - 2023
  • Figure 4-35: ASP by Country, Robotic Catheter System Market, Europe, 2013 - 2023 (€)
  • Figure 4-36: ASP by Country, Robotic Catheter System Market, Europe, 2013 - 2023 (US$)
  • Figure 4-37: Market Value by Country, Robotic Catheter System Market, Europe, 2013 - 2023 (€M)
  • Figure 4-38: Market Value by Country, Robotic Catheter System Market, Europe, 2013 - 2023 (US$M)
  • Figure 4-39: Drivers and Limiters, Robotic Catheter System Market, Europe, 2016
  • Figure 4-40: Leading Competitors, Robotic Catheter System Market, Europe, 2016
  • Figure 4-41: Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023
  • Figure 4-42: Units Sold by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023
  • Figure 4-43: ASP by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023 (€)
  • Figure 4-44: ASP by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023 (US$)
  • Figure 4-45: Market Value by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023 (€M)
  • Figure 4-46: Market Value by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2013 - 2023 (US$M)
  • Figure 4-47: Drivers and Limiters, Robotic Assisted Orthopedic Surgery Market, Europe, 2016
  • Figure 4-48: Leading Competitors by Country, Robotic Assisted Orthopedic Surgery Market, Europe, 2016
  • Figure 6-1: Robotic Assisted Surgery Press Release Summary
  • Figure 6-2: Surgical Navigation Press Release Summary
Back to Top
전화 문의
F A Q